Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK A Massachusetts U.S. District Court judge has dismissed ex-Pfizer marketing vice president Peter Rost’s whistle-blowing case against his former employers, Pharmacia and Pfizer.
Rost had alleged that Pharmacia illegally sold Genotropin, a human-growth-hormone brand, to anti-aging “specialists” who falsely promised wealthy clients the fountain of youth.
Pfizer acquired Pharmacia in April 2003, despite Rost’s warnings about the “off-label” (i.e., legally unapproved) sales, he claimed.
In the Aug. 31 ruling, Judge Joseph Tauro wrote that for Rost’s suit to succeed, he needed to produce evidence that Pharmacia and Pfizer had orchestrated the submission of bills to the government for reimbursement for “off-label” Genotropin treatments.
For
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in